期刊文献+

终末期肾脏病患者并发神经系统症状的病因分析 被引量:1

Etiological analysis of neurologic complications in patients with end-stage kidney diseases
下载PDF
导出
摘要 目的:探讨终末期肾脏病患者并发神经系统症状的病因。方法:回顾性分析出现神经系统并发症终末期肾脏病患者的临床资料。结果:终末期肾脏病患者出现神经系统症状原因主要与毒素蓄积、内环境的紊乱、失衡综合征、透析欠充分、透析脑病、基础病变、脑血管病变、药物因素、社会心理因素等有关。结论:终末期肾脏病患者出现神经系统并发症与多因素有关,早期个体化综合性治疗,可有效提高患者的生存期和生存质量。 Objective To study the reasons of neurologic complications in patients with end-stage kidney diseases. Methods: The clinical data of the patients with end-stage kidney diseases combined with neurologic complications were retrospectively analyzed. Results : It showed that the reasons of the neurologic complications in the patients with end-stage kidney diseases were : uremia toxin storage, internal environment disturbance, disequilibrium syndrome, non-sufficient dialysis, dialysis encephalopathy, basic pathologi-cal change, cerebrovascular diseases, and psychosocial and drug factors. Conclusions: The neurologic complications in the patients with end-stage kidney diseases are related to multiple factors. An early individualized comprehensive treatment can effectively improve the patients 爷 life span and quality of life.
出处 《中国民康医学》 2017年第12期13-15,共3页 Medical Journal of Chinese People’s Health
基金 山东省医药卫生科技发展计划项目(项目编号2014WS0476)
关键词 终末期肾脏病 神经精神症状 病因 并发症 End-stage kidney disease Neuropsychiatric symptom Etiology Complication
  • 相关文献

参考文献4

二级参考文献80

  • 1周盾,王悦,孙洞箫,贾艳秋,吴军.尿毒症血液透析患者脂质代谢的临床研究[J].中国现代医学杂志,2005,15(20):3140-3141. 被引量:8
  • 2陈香美,初启江.不同血液净化方式对蛋白结合类毒素的清除作用[J].中国血液净化,2005,4(11):581-584. 被引量:50
  • 3Moe SM, Sprague SM. Uremic encephalopathy [J]. Clin Nephrol, 1994, 42 (4): 251-256.
  • 4Krishnan AV, Phoon RK, Pussell BA, et al. Sensory nerve excitability and neuropathy in end-stage kidney disease [ J]. J Neurol Neurosurg Psychiatry, 2006, 77 (4) : 548-551.
  • 5Meyer TW, Hostetter TH. Uremia [J]. N Engl J Med, 2007, 357(13): 1316-1325.
  • 6Bostock H, Waiters RJ, Andersen KV, et al. Has potassium been prematurely discarded as a contributing factor to the development of uraemic neuropathy? [J]. Nephrol Dial Transplant, 2004, 19 (5): 1054-1057.
  • 7Kiernan MC, Waiters R J, Andersen KV, et al. Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia[J]. Brain, 2002, 125 (6) : 1366-1378.
  • 8Enomoto A, Takeda M, Taki K, et al. Interactions of human organic anion as well as cation transporters with indoxyl sulfate [ J]. Eur J Pharmacol, 2003, 466 (1-2) : 13-20.
  • 9Krishnan AV, Pussell BA, Kieman MC, et al. Neuromuscular disease in the dialysis patient: an update for the nephrologist [J]. Semin Dial, 2009, 22 (3) : 267-278.
  • 10Wilboum AJ, Furlan AJ, Hulley W, et al. Ischemic monomelic neuropathy EJ]. Neurology, 1983, 33 (4) : 447-451.

共引文献33

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部